Old Web
English
Sign In
Acemap
>
authorDetail
>
Joachim Tillner
Joachim Tillner
Diabetes mellitus
Endocrinology
Glucagon
Internal medicine
Medicine
4
Papers
93
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Prolonged Glucagon Infusion Does Not Affect Energy Expenditure in Individuals with Overweight/Obesity: A Randomized Trial.
2021
Obesity
Katie L Whytock
Elvis A. Carnero
Rick B. Vega
Joachim Tillner
Christopher Bock
Karthik Chivukula
Fanchao Yi
Christian Meyer
Steven R. Smith
Lauren M. Sparks
Show All
Source
Cite
Save
Citations (1)
A Metabolomic Signature of Glucagon Action in Healthy Individuals With Overweight/Obesity.
2021
Journal of the Endocrine Society
Rick B. Vega
Katie L Whytock
Johan Gassenhuber
Britta Goebel
Joachim Tillner
Inoncent Agueusop
Agnieszka D. Truax
Gongxin Yu
Elvis A. Carnero
Nidhi Kapoor
Stephen J. Gardell
Lauren M. Sparks
Steven R. Smith
Show All
Source
Cite
Save
Citations (1)
A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials
2019
Diabetes, Obesity and Metabolism
Joachim Tillner
Maximilian G. Posch
Frank Wagner
Lenore Teichert
Youssef Hijazi
Christine Einig
Stefanie Keil
Torsten Haack
Michael Wagner
Martin Bossart
Philip J. Larsen
Show All
Source
Cite
Save
Citations (83)
Tolerability, safety and pharmacokinetics of the novel Cathepsin A inhibitor SAR164653 in healthy subjects
2016
Clinical pharmacology in drug development
Joachim Tillner
Anne Lehmann
Tobias Paehler
Zoltan Lukacs
Sven Ruf
Thorsten Sadowski
Jean-Louis Pinquier
Hartmut Ruetten
Show All
Source
Cite
Save
Citations (8)
1